Microdosing Tirzepatide
4 Week Supply

Microdosing tirzepatide refers to the use of a lower, individualized dose than may be used in standard treatment protocols. This approach may be considered for eligible patients who prefer a gradual introduction to treatment or whose provider determines that a lower dose may be appropriate based on their health history, treatment goals, medication response, or tolerance.

Tirzepatide acts on GIP and GLP-1 pathways involved in appetite, food intake, and blood sugar regulation. When prescribed as part of a medically supervised weight-management program, it may help some patients manage appetite and make sustainable nutrition and lifestyle changes.

This option includes a 4-week supply and a provider evaluation for consideration of compounded tirzepatide. A licensed provider will review your medical history and questionnaire responses to determine whether treatment is appropriate and establish the prescribed dose. No laboratory work is required for initial consideration, although the provider may request additional information or testing based on your individual needs.

“Microdosing” is not a standardized medical dosing category. The dose and treatment plan are determined by the prescribing provider. Purchasing an evaluation does not guarantee approval, a prescription, or specific weight-loss results. If approved, use the medication only as directed by your provider and dispensing pharmacy.